Cargando…
P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430982/ http://dx.doi.org/10.1097/01.HS9.0000971292.12638.60 |
| _version_ | 1785091090256232448 |
|---|---|
| author | Zheng, Zhong Zhang, Huilai Zhou, Keshu Zhou, Hui Zhang, LI LI, Caixia Zhou, Min Qian, Wenbin LI, Zhiming Zhang, Qingyuan Cheng, Ying Peng, Liu LI, Zhenyu Su, Liping LI, Fei Sun, Xiuhua Wang, Jingwen Gao, Yuhuan Zhao, Xielan LI, Kunyan Ding, Kaiyang Zhu, Zunmin Wang, Ying Jing, Hongmei Xu, Xiaohong Wang, Xin Sun, Zimin Gao, Da Zhao, Wei-LI |
| author_facet | Zheng, Zhong Zhang, Huilai Zhou, Keshu Zhou, Hui Zhang, LI LI, Caixia Zhou, Min Qian, Wenbin LI, Zhiming Zhang, Qingyuan Cheng, Ying Peng, Liu LI, Zhenyu Su, Liping LI, Fei Sun, Xiuhua Wang, Jingwen Gao, Yuhuan Zhao, Xielan LI, Kunyan Ding, Kaiyang Zhu, Zunmin Wang, Ying Jing, Hongmei Xu, Xiaohong Wang, Xin Sun, Zimin Gao, Da Zhao, Wei-LI |
| author_sort | Zheng, Zhong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430982 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309822023-08-17 P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY Zheng, Zhong Zhang, Huilai Zhou, Keshu Zhou, Hui Zhang, LI LI, Caixia Zhou, Min Qian, Wenbin LI, Zhiming Zhang, Qingyuan Cheng, Ying Peng, Liu LI, Zhenyu Su, Liping LI, Fei Sun, Xiuhua Wang, Jingwen Gao, Yuhuan Zhao, Xielan LI, Kunyan Ding, Kaiyang Zhu, Zunmin Wang, Ying Jing, Hongmei Xu, Xiaohong Wang, Xin Sun, Zimin Gao, Da Zhao, Wei-LI Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430982/ http://dx.doi.org/10.1097/01.HS9.0000971292.12638.60 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zheng, Zhong Zhang, Huilai Zhou, Keshu Zhou, Hui Zhang, LI LI, Caixia Zhou, Min Qian, Wenbin LI, Zhiming Zhang, Qingyuan Cheng, Ying Peng, Liu LI, Zhenyu Su, Liping LI, Fei Sun, Xiuhua Wang, Jingwen Gao, Yuhuan Zhao, Xielan LI, Kunyan Ding, Kaiyang Zhu, Zunmin Wang, Ying Jing, Hongmei Xu, Xiaohong Wang, Xin Sun, Zimin Gao, Da Zhao, Wei-LI P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY |
| title | P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY |
| title_full | P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY |
| title_fullStr | P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY |
| title_full_unstemmed | P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY |
| title_short | P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY |
| title_sort | p1099: a phase ii, multicenter, single-arm study of parsaclisib, a pi3kδ inhibitor, in relapsed or refractory follicular lymphoma in china: updated results from the study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430982/ http://dx.doi.org/10.1097/01.HS9.0000971292.12638.60 |
| work_keys_str_mv | AT zhengzhong p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT zhanghuilai p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT zhoukeshu p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT zhouhui p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT zhangli p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT licaixia p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT zhoumin p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT qianwenbin p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT lizhiming p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT zhangqingyuan p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT chengying p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT pengliu p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT lizhenyu p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT suliping p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT lifei p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT sunxiuhua p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT wangjingwen p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT gaoyuhuan p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT zhaoxielan p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT likunyan p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT dingkaiyang p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT zhuzunmin p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT wangying p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT jinghongmei p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT xuxiaohong p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT wangxin p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT sunzimin p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT gaoda p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy AT zhaoweili p1099aphaseiimulticentersinglearmstudyofparsaclisibapi3kdinhibitorinrelapsedorrefractoryfollicularlymphomainchinaupdatedresultsfromthestudy |